Seroatlas · Human Serome Atlas

B4GALT3

Beta-1,4-galactosyltransferase 3

Also known as: B4GT3_HUMAN, beta4Gal-T3

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O60512
Gene
B4GALT3
Ensembl
ENSG00000158850
Chromosome
1
Canonical length
393 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Golgi apparatus,Cytosol

OverviewNCBI Gene

This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene encodes an enzyme that may be mainly involved in the synthesis of the first N-acetyllactosamine unit of poly-N-acetyllactosamine chains. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2010]

Canonical amino-acid sequenceUniProt

393 residues, UniProt reviewed canonical sequence.

>O60512|B4GALT3
     1  MLRRLLERPC TLALLVGSQL AVMMYLSLGG FRSLSALFGR DQGPTFDYSH PRDVYSNLSH
    61  LPGAPGGPPA PQGLPYCPER SPLLVGPVSV SFSPVPSLAE IVERNPRVEP GGRYRPAGCE
   121  PRSRTAIIVP HRAREHHLRL LLYHLHPFLQ RQQLAYGIYV IHQAGNGTFN RAKLLNVGVR
   181  EALRDEEWDC LFLHDVDLLP ENDHNLYVCD PRGPRHVAVA MNKFGYSLPY PQYFGGVSAL
   241  TPDQYLKMNG FPNEYWGWGG EDDDIATRVR LAGMKISRPP TSVGHYKMVK HRGDKGNEEN
   301  PHRFDLLVRT QNSWTQDGMN SLTYQLLARE LGPLYTNITA DIGTDPRGPR APSGPRYPPG
   361  SSQAFRQEML QRRPPARPGP LSTANHTALR GSH

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against B4GALT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.32
Highest tissue expression
33 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 33 nTPM
  • pituitary gland: 32 nTPM
  • salivary gland: 30 nTPM
  • spleen: 30 nTPM
  • ovary: 28 nTPM
  • adipose tissue: 27 nTPM

Single-cell type

  • syncytiotrophoblasts: 145 nCPM
  • extravillous trophoblasts: 120 nCPM
  • esophageal apical cells: 92 nCPM
  • plasma cells: 76 nCPM
  • migrating cytotrophoblasts: 68 nCPM
  • differentiating spermatogonia: 59 nCPM

Immune cell

  • T-reg: 43 nTPM
  • plasmacytoid DC: 38 nTPM
  • gdT-cell: 27 nTPM
  • memory B-cell: 26 nTPM
  • memory CD8 T-cell: 26 nTPM
  • NK-cell: 26 nTPM

Brain region

  • hypothalamus: 22 nTPM
  • hippocampal formation: 16 nTPM
  • basal ganglia: 16 nTPM
  • cerebral cortex: 16 nTPM
  • thalamus: 15 nTPM
  • amygdala: 15 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.64
gnomAD pLI
0.01
gnomAD missense Z
1.46
DepMap mean gene effect
-0.19
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 16% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of B4GALT3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads B4GALT3 as an antibody target. Whether an autoantibody or antibody against B4GALT3 could matter depends on whether native B4GALT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

B4GALT3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label B4GALT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/B4GALT3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...